- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/85 - Nitriles in position 3
Patent holdings for IPC class C07D 213/85
Total number of patents in this class: 330
10-year publication summary
|
28
|
27
|
21
|
22
|
31
|
26
|
22
|
31
|
21
|
19
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Syngenta Crop Protection AG | 6730 |
14 |
| Bristol-myers Squibb Company | 4757 |
10 |
| King Faisal University | 934 |
10 |
| Bayer Pharma AG | 1009 |
9 |
| Novaled GmbH | 489 |
9 |
| Takeda Pharmaceutical Company Limited | 2700 |
7 |
| Peloton Therapeutics, Inc. | 38 |
7 |
| ChemoCentryx, Inc. | 361 |
6 |
| F. Hoffmann-La Roche AG | 7808 |
5 |
| The Regents of the University of California | 20815 |
5 |
| Boehringer Ingelheim International GmbH | 4486 |
5 |
| Amgen Inc. | 4440 |
5 |
| Glaxosmithkline Intellectual Property Development Limited | 780 |
5 |
| Lario Therapeutics Ltd | 14 |
5 |
| Novartis AG | 10173 |
4 |
| Monsanto Technology LLC | 8575 |
4 |
| Amyris, Inc. | 371 |
4 |
| FMC Corporation | 810 |
4 |
| Icahn School of Medicine at Mount Sinai | 1045 |
4 |
| Nippon Soda Co., Ltd. | 885 |
4 |
| Other owners | 204 |